本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Bicycle Therapeutics Limited

8.15
-0.0300-0.37%
成交量:8.06萬
成交額:65.41萬
市值:5.65億
市盈率:-2.33
高:8.39
開:8.18
低:7.99
收:8.18
52周最高:25.39
52周最低:6.10
股本:6,930.65萬
流通股本:307.84萬
量比:0.97
換手率:2.62%
股息:- -
股息率:- -
每股收益(TTM):-3.5033
每股收益(LYR):-2.9039
淨資產收益率:-31.42%
總資產收益率:-19.07%
市淨率:0.84
市盈率(LYR):-2.81

資料載入中...

公司資料

公司名字:
Bicycle Therapeutics Limited
交易所:
NASDAQ
成立時間:
2009
員工人數:
305
公司地址:
Portway Building,Blocks A & B,Granta Park,Great Abington,Cambridge,Cambridgeshire,United Kingdom
郵編:
CB21 6GS
傳真:
- -
簡介:
Bicycle Therapeutics plc於2017年10月27日根據英格蘭和威爾士法律註冊成立。該公司是一家臨床階段的生物製藥公司,開發一種新型藥物,他們稱之為自行車,用於現有治療方法不足的疾病。自行車是完全合成的短肽,限制形成兩個環,穩定它們的結構幾何形狀。該約束旨在賦予高親和力和選擇性,並且由分子呈現的相對大的表面積允許靶向藥物,其歷史上對於非生物學方法是難以處理的。自行車是一種獨特的治療方式,將通常與生物製劑相關的藥理學與小分子的製造和藥代動力學或PK特性相結合。

董事

名稱
職位
Felix J. Baker
Chairman of the Board
Kevin Lee
Director and Chief Executive Officer
Alessandro Riva
Independent Director
Greg Winter
Independent Director
Janice Bourque
Independent Director
Jose Carlos Gutierrez Ramos
Independent Director
Stephen Sands
Independent Director
Charles Swanton
Director
Fabrice Andre
Director
Hervé Hoppenot
Director
Roger Danse
Director

股東

名稱
職位
Kevin Lee
Director and Chief Executive Officer
Alistair Milnes
Chief Operating Officer
Alethia Young
Chief Financial Officer
Jim MacDonald Clink
Senior Vice President and Head of Business Development
Eric Westin
Chief Medical Officer
Michael Charles Ferguson Hannay
Chief Product Officer and Chief Supply Chain Officer
Michael Skynner
Chief Technology Officer
Travis Thompson
Chief Accounting Officer